*On 3rd January 2024, Dr Mario Polywka has agreed to step in as interim CEO after Dr Werner Lanthaler stepped down as CEO. His Supervisory Board mandate is inactive while he works in his role as interim CEO for up to 12 months.
Prof. Dr Iris Löw-Friedrich
Chief Medical Officer of UCB S.A., Chairperson of the Supervisory Board of Evotec SE
Roland Sackers
Chief Financial Officer and Managing Director of QIAGEN N.V., Vice Chairman of the Supervisory Board of Evotec SE
Camilla Macapili Languille
Head of Life Sciences, Mubadala Investment Company
Dr Elaine Sullivan
Non-Executive Director at the IP Group plc, hVIVO plc and Nykode Therapeutics ASA
Dr Constanze Ulmer-Eilfort
Partner of the law firm Peters, Schönberger & Partner (PSP München)
Dr Mario Polywka
Interim CEO of Evotec SE*
Prof. Dr Iris Löw-Friedrich
Chief Medical Officer of UCB S.A., Chairperson of the Supervisory Board of Evotec SE
Roland Sackers
Chief Financial Officer and Managing Director of QIAGEN N.V., Vice Chairman of the Supervisory Board of Evotec SE
Camilla Macapili Languille
Head of Life Sciences, Mubadala Investment Company
Dr Elaine Sullivan
Non-Executive Director at the IP Group plc, hVIVO plc and Nykode Therapeutics ASA
Dr Constanze Ulmer-Eilfort
Partner of the law firm Peters, Schönberger & Partner (PSP München)
Dr Mario Polywka
Interim CEO of Evotec SE*
CVs of all Supervisory Board members of Evotec SE
TOP